Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	93.44	92.58	45.93	15.39	44.14	42.48
Depreciation & Amortization	19	19	21.69	24.14	22.7	23.74
Other Amortization	0.13	0.13	-	1.78	1.78	1.78
Loss (Gain) From Sale of Assets	0.23	0.23	0.04	-0.03	-	-0.03
Asset Writedown & Restructuring Costs	2.75	2.75	0.2	19.93	0.08	0.08
Loss (Gain) From Sale of Investments	-3.5	-3.5	-3.51	-2.31	-1.48	-0.91
Provision & Write-off of Bad Debts	-1.25	-1.25	0.67	-7.02	6.64	-1.13
Other Operating Activities	48.37	0.72	2.5	0.39	-0.36	-1.03
Change in Accounts Receivable	26.55	26.55	-14.57	170.44	6.1	86.19
Change in Inventory	-18.74	-18.74	17.63	-13.42	-12.09	-12.52
Change in Accounts Payable	8.84	8.84	-8.53	-46.74	47.54	-52.44
Change in Other Net Operating Assets	-1.78	-1.78	48.01	3.04	-43.92	19.75
Operating Cash Flow	172.22	123.72	111.57	166.88	68.45	109.52
Operating Cash Flow Growth	94.16%	10.89%	-33.14%	143.79%	-37.50%	7.65%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-8.83	-8.5	-12.24	-3.18	-3.2	-25.2
Sale of Property, Plant & Equipment	0.17	0.15	0.14	0.08	0	0.06
Cash Acquisitions	-	-	-	-	-	-29.45
Investment in Securities	-	-	28.54	-42.14	-	-
Other Investing Activities	6.58	6.51	2.56	2.24	1.48	0.91
Investing Cash Flow	-2.09	-1.84	19	-43	-1.72	-53.68

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	22.11	22.8	11	50	-
Total Debt Issued	9.61	22.11	22.8	11	50	-
Short-Term Debt Repaid	-	-33.66	-11	-50	-	-40
Long-Term Debt Repaid	-	-	-	-	-	-0.09
Total Debt Repaid	-44.91	-33.66	-11	-50	-	-40.09
Net Debt Issued (Repaid)	-35.3	-11.55	11.8	-39	50	-40.09
Issuance of Common Stock	24.51	24.51	-	-	-	-
Repurchase of Common Stock	-	-	-50.03	-0.02	-2.64	-3.01
Common Dividends Paid	-23.66	-23.84	-6.04	-20.28	-19.77	-15.27
Other Financing Activities	6.46	-	-	-	-	-0.83
Financing Cash Flow	-27.99	-10.88	-44.26	-59.3	27.59	-59.2

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-1.11	-0.73	0.24	-0	-0.02	-0.02
Net Cash Flow	141.03	110.27	86.54	64.57	94.31	-3.38

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	163.39	115.22	99.33	163.7	65.26	84.33
Free Cash Flow Growth	103.00%	16.00%	-39.32%	150.86%	-22.62%	33.20%
Free Cash Flow Margin	24.38%	18.11%	15.24%	24.54%	7.62%	11.62%
Free Cash Flow Per Share	0.89	0.62	0.54	0.85	0.34	0.44
Levered Free Cash Flow	155.91	98	22.04	135.69	88.29	12.88
Unlevered Free Cash Flow	156.43	98.63	22.32	136.43	88.8	13.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Interest Paid	-	-	-	-	-	0.83
Cash Income Tax Paid	102.8	98.06	96.36	95.33	86.77	86.95
Change in Working Capital	13.04	13.04	44.05	114.62	-5.04	44.54

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error